[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600349":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":20,"locations":21,"responsibleParty":45,"collaborators":20,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":20,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":20,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":24,"whyStopped":20,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Bangladesh Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Male Parkinson's disease patients with hypovitaminosis D","EXPERIMENTAL","15 Male Parkinson's disease patients with hypovitaminosis D will be supplemented with vitamin D orally 50,000 IU\u002Fweek for 8 weeks",[13],"Dietary Supplement: vitamin D3 capsule",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIETARY_SUPPLEMENT","vitamin D3 capsule","Administration of vitamin D3 capsule 50,000 IU\u002Fweek for 8 weeks",[9],null,[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Bangladesh medical university","RECRUITING","Dhaka","Shahbag","1000","Bangladesh","BD",{"type":31,"coordinates":32},"Point",[33,34],90.40744,23.7104,{"lat":34,"lon":33},[37,42],{"name":38,"role":39,"phone":40,"phoneExt":20,"email":41},"Jannatul Ferdoush Sumi, MBBS, MD Resident (phase B)","CONTACT","+8801875236686","jannatsumi37@gmail.com",{"name":43,"role":39,"phone":44,"phoneExt":20,"email":20},"SUAYYA BINTE RAZZAQUE, MBBS,MD RESIDENT PHASE B","+ 8801731660607",{"type":46,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Jannatul Ferdoush Sumi","MD resident , Department of Physiology, Bangladesh Medical University, Principal investigator,","100600349","effect-of-vitamin-d3-on-brain-waves-in-male-parkinsons-patients-with-low-vitamin-d-a-qeeg-study-100600349",false,"NCT07096336","Effect of Vitamin D3 on Brain Waves in Male Parkinson's Patients With Low Vitamin D: A qEEG Study","Effect of Vitamin D3 Supplementation on Brain Waves in Male Parkinson's Disease Patients With Hypovitaminosis D : A Quantitative Electroencephalogram Analysis","Inclusion Criteria:\n\n* Male Patients with PD up to stage 3 according to Hoehn and Yahr (H-Y) scale\n* Age: 51years to70 years\n* BMI: 18.5-24.9 kg\u002Fm2\n* Hypovitaminosis D (Serum 25(OH)D level \\\u003C30 ng\u002Fml)\n* Patients on Levodopa therapy\n\nExclusion Criteria:\n\n* Already taking vitamin D3 supplements\n* Current use of medication\u002Fsubstances known to affect neuronal excitability or EEG patterns, such as - sedatives, antidepressant, antipsychotics, alcohol.\n* Patients who are currently suffering from following diseases\n\n  * Neurological disorders (Migraine, epilepsy)\n  * Cardiovascular disorders (Myocardial infarction, hypertension, cardiac arrhythmia, heart failure)\n  * Respiratory disorders (Bronchial asthma, COPD)\n  * Psychiatric illness (e.g., schizophrenia, major depression, bipolar disorder, severe dementia)\n* With biochemical evidence of-\n\n  * Hypercalcemia\n  * Renal insufficiency\n  * Liver diseases\n  * Endocrine disorders (uncontrolled diabetes mellitus, Hypothyroidism, Hyperthyroidism)\n* Active smoker","MALE","51 Years","70 Years",{"count":60,"type":61},15,"ESTIMATED","INTERVENTIONAL",[64],"NA","This is an experimental study (Interventional self-controlled trial, pretest-posttest design). The goal of this clinical trial is to evaluate the effect of vitamin D3 supplementation on quantitative EEG in male Parkinson's disease patients with hypovitaminosis D.\n\nThe main question it aims to answer is:\n\nVitamin D3 supplementation has effect on brain waves in male Parkinson's disease patients with hypovitaminosis D.\n\nResearcher will compare the effect of vitamin D3 supplementation on brain waves in male Parkinson's disease patients with hypovitaminosis D with their pre intervention ( baseline ) condition on brain waves to assess whether there will be any improvement of brain electrical activity by quantitative electroencephalogram (QEEG).\n\nParticipants will :\n\nTake vitamin D3 orally for 8 weeks (50,000 IU\u002Fweek) Visit the medical university after 8 weeks for evaluation of serum 25(OH)D level and QEEG Must bring the empty strips of vitamin D supplement with them during their visit.",[67],"PARKINSON DISEASE (Disorder)",[69,70,71,72,73,74,75,76,77],"Parkinson's disease","Vitamin D3","Quantitative EEG (qEEG)","Brain wave","25-hydroxyvitamin D","Spectral power","Dopaminergic neurons","EEG frequency bands","Neurodegeneration","2025-07-29",{"date":80,"type":81},"2025-07-31","ACTUAL",{"date":83,"type":81},"2025-07-15",{"date":85,"type":61},"2025-11",{"name":5,"class":6},1]